Life Scientist > Biotechnology

Oncaidia goes public with mAb

26 July, 2007 by Kate McDonald

SA company offers IPO to further commercialise monoclonal antibody technology.


Pigs and pathogens: understanding antibiotic resistance

26 July, 2007 by Joanne Finlay

Research shows that the use of one antibiotic increases resistance but also increases the carriage of resistance genes against other classes of antibiotics.


PROFILE: Seek and we shall provide

25 July, 2007 by Kate McDonald

A Brisbane biomedical scientist has set up an online matching service for researchers. And before you ask, it's aimed at finding professional partners, not romantic ones.


Regular boost for high fibre research

25 July, 2007 by Staff Writers

CSIRO and universities come together to research new grain varieties with higher fibre.


Microbicide well tolerated, even by men

24 July, 2007 by Staff Writers

Starpharma's anti-HIV and herpes microbicide is well tolerated by men, the company told the IAS conference today.


Bioscience heading to Honkers

23 July, 2007 by External Press Release Author

Bioscience companies are invited to attend a trade mission to Hong Kong.


737 boosts leukaemia drugs

19 July, 2007 by Staff Writers

Study finds Abbott Laboratories' ABT-737 increases therapy effectiveness.


Biota starts RSV trial

17 July, 2007 by Staff Writers

Biota and partner MedImmune begin antiviral trial for respiratory virus.


Starpharma's VivaGel on trial

10 July, 2007 by Kate McDonald

NIH-funded trial of Starpharma's VivaGel microbicide under way in US.


Monoclonal antibodies for Monash

05 July, 2007 by Staff Writers

Monash University and Tecan to build monoclonal antibody production facility.


Cheers to beer and all things yeasty

02 July, 2007 by Kate McDonald

500 international yeast biologists have descended on Melbourne.


Commercialisation bootcamp in Brisbane

28 June, 2007 by Staff Writers

'Bootcamp' for Brisbane researchers interested in learning more about the business of commercialisation.


Giaconda begins hep C trial

27 June, 2007 by Staff Writers

Combination therapy trial for refractory hep C begins.


Bone repair trial yields growth

22 June, 2007 by Kate McDonald

Mesoblast announces strong interim results in fracture repair trial.


VitroGro gets topical

21 June, 2007 by Kate McDonald

Biologic classification to fast-track VitroGro development.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd